TYPEZERO TECHNOLOGIES, LLC — Department of Health and Human Services SBIR Phase I: ? DESCRIPTION (provided by applicant): Despite major advances in pharmaceuticals and
TYPEZERO TECHNOLOGIES, LLC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $224,354
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- DK13-028
- NAICS
- —
- Place of performance
- VA
- Period
- —
Description
? DESCRIPTION (provided by applicant): Despite major advances in pharmaceuticals and medical device technology, the ability to safely and effectively control blood glucose in patients with Type 1 diabetes has remained a recalcitrant challenge and a significant source of human suffering and economic cost. With the advent of continuous glucose monitoring (CGM), increasing effort has been focused on the development of artificial pancreas (AP) systems using CGM coupled with insulin pump via closed-loop control (CLC) algorithms. Integration of these disparate technologies and implementation in a commercial product has faced numerous challenges to date. TypeZero Technologies' objective is the commercialization of the robust and extensively tested Diabetes Assistant (DiAs) software platform and supporting technology into a commercial-grade device hub designed to organize and control a network of medical devices for the improved management of blood glucose in the context of Type 1 diabetes. The DiAs prototype